FDA Pediatric Cancer Panel: Increase International Collaboration

Clinical Trials Advisor
A A
In a June meeting, the FDA’s pediatric cancer advisory panel suggested further international cooperation and emphasized the need for tailoring trials to their specific diseases, while recommending against the use of placebos in pediatric cancer drug trials.

To View This Article:

Login

Subscribe To Clinical Trials Advisor